Ugandan scientists plan to develop vaccine for crimean-congo hemorrhagic fever
Available studies indicate that about three billion people globally, are at a risk of contracting the zoonotic viral illness, and yet there is no licensed vaccine nor antiviral drug available to curb the looming scourge.
PREMIUM Health
Assistant Prof, Sheia Balinda, the principal investigator of the study. (Photo by Julius Luwemba)
By NewVision Reporter
Journalists @NewVision
______________
Scientists under the Uganda Virus Research Institute and Medical Research Council (MRC), have embarked on a study to develop a vaccine that will tackle crimean-congo hemorrhagic fever (CCHF)